News
Lower HCRU and costs may be reflective of improved patient care.
HPV cfDNA is a highly effective tumor marker for monitoring disease progression and treatment response in HPV-positive cervical cancer, offering valuable insights for guiding clinical decisions in ...
Vir Biotechnology, Inc. ( NASDAQ: VIR) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 4:05 PM EDT ...
A nasal allergy test showed strong diagnostic performance, with sensitivity exceeding 75% and specificity approaching 90% for ...
6don MSN
Antigen amplification strategy shows promise for more precise next-generation immunotherapies
Tumor immunotherapies, especially those leveraging T-cells to identify and eliminate cancer cells, represent a major ...
At the top of the list is the BinaxNOW COVID-19 Antigen Self-Test. Prices are consistent in stores and online. A two-pack kit ...
The recent commentary by Manning et al highlights difficulties comparing results of gastrointestinal microbiome cohort studies.1 They demonstrate how methodological heterogeneity can substantially ...
While the coronavirus might be in the rear-view mirror for many, the number of positive cases for a new variant of Covid-19 ...
Non-essential amino acids such as glutamine have been known to be required for T cell general activation through sustaining basic biosynthetic processes, including nucleotide biosynthesis, ATP ...
Tom's Hardware on MSN
Display Testing Explained: How We Test PC Monitors
Our display benchmarks help you decide what screen to put on your desktop. In order to provide greater insight into our PC ...
News-Medical.Net on MSN
Tracking antibodies reveals four distinct COVID-19 vaccine responses
Two healthcare workers get COVID-19 vaccinations on the same day. Both show strong antibody responses initially, but six ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results